SAN DIEGO, March 09, 2017 (GLOBE NEWSWIRE) — Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 10:45 a.m. JST on Tuesday, March 14, at the Biotechnology Innovation Organization (BIO) Asia International Conference (Tokyo – March 14-15). A copy of the presentation will be available through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.
Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.
CONTACT: Tony Ramos (858) 646-1127 Website: www.vical.com